Cardiac procedures in ST-segment-elevation myocardial infarction - the influence of age, geography and Aboriginality

Lee K Taylor1, Michael A Nelson2, Marianne Gale3

  • 1Centre for Epidemiology and Evidence, NSW Ministry of Health, Sydney, Australia.

Insights

Timely reperfusion for ST-segment elevation myocardial infarction (STEMI) is crucial. This study found that older patients and those in regional areas have reduced access to timely reperfusion therapies like PCI, highlighting a gap in care for Aboriginal people with STEMI.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Acute ST-segment elevation myocardial infarction (STEMI) requires prompt blood flow restoration to minimize heart damage and improve outcomes.
  • Demographic factors influence hospitalisation rates and treatment timeliness for STEMI.

Purpose of the Study:

  • To examine the association between demographic factors and STEMI hospitalisation rates.
  • To analyze the time to reperfusion therapies (angiography, Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Graft (CABG)) for STEMI patients in NSW and ACT, Australia.

Main Methods:

  • Observational cohort study utilizing linked population health data from NSW and ACT.
  • Inclusion of hospitalisation records and Medicare Benefits Schedule (MBS) data for STEMI patients aged 35 and over (July 2010 - June 2014).
  • Survival analysis with competing risk of death was employed to determine time to cardiac procedures.

Main Results:

  • STEMI hospitalisations were more common in males (71%) and older individuals (55% aged 65+).
  • Reperfusion rates (angiography, PCI) decreased significantly with age and were lower in regional areas compared to major cities.
  • Aboriginal people with STEMI were younger, more likely to reside outside major cities, and had similar reperfusion rates to non-Aboriginal people when controlling for age and remoteness.

Conclusions:

  • There is a critical need to enhance access to timely reperfusion therapies for STEMI, particularly for older patients and those in regional areas.
  • Aboriginal people with STEMI face significant disparities in accessing definitive revascularisation outside major cities.
  • Improving regional access to timely reperfusion is essential to reduce cardiovascular outcome gaps between Aboriginal and non-Aboriginal populations.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
135
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
158
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
179
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
127
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
135
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
289